Dr. Tetsu Yung is the founder of TETSUNAGI Consulting, Inc., bringing over 20 years of R&D experience, from basic research as a post-doc at the Tokyo Institute of Technology, to oversight of the entire R&D pipeline at Eisai under the CSO, and as project manager and Head of the CTL (Clinical Team Lead) Group at Fortrea Japan until 2023. He holds a PhD in cellular and molecular biology and an MBA in Finance and International Management. Other than English and Japanese, Tetsu is also fluent in Mandarin, French, and Spanish.